Trial intelligence / Profile preview

Terlipressin After EVL in Acute Variceal Haemorrhage (TEVL)

NCT03584087Phase 4Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
May 2018
Primary completion
Jul 2019
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of terlipressin in Variceal hemorrhage (VH), sponsored by Post Graduate Institute of Medical Education and Research. Started May 2018; status: completed.

02

Drugs

terlipressin
03

Conditions

Variceal hemorrhage (VH)

Beyond the preview

Go deeper on NCT03584087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03584087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call